.5) in 2014-15 (P-trend<0.0001), OR 2.9 (95%CI 2.3,3.7), adjusted OR 2.7 (95%CI 2.1,3.4). The strongest negative predictors to receive NS-AH were vomiting and hospital admission, while allergic rhinitis was the strongest positive predictor. Within visits for allergy, NS-AH/AH showed no increase over time (P-trend50.8818) at an average of 13.1% (95%CI 11.8,14.2). CONCLUSIONS: Between 2006-15, overall ED use of NS-AH increased. However, less than 15% of AH use was an NS-AH and allergy visits had no increased utilization overtime. Education is needed to promote NS-AH use for ED allergic reaction management.
